Solar Simulator for Visible Light and UVA1 Skin Testing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current sunscreen testing protocols primarily focus on ultraviolet (UV) radiation, neglecting the protective needs against visible light (VL) and long wavelength ultraviolet A1 (UVA1) radiation, which are significant contributors to skin damage and cancer.
Innovation Solution
A system and method utilizing a solar simulator to administer a combination of visible light and long wavelength UVA1 radiation to a skin sample, with a customized filter combination generating a spectral output of approximately 2.0% UVA1 and 97.3% VL, along with 0.7% Infrared radiation, to simulate natural sunlight exposure.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current sunscreen testing protocols focus only on ultraviolet radiation, then testing simplicity is maintained, but protection efficacy against visible light and UVA1 radiation is insufficient
Solution Approach 1:
The patent segments the solar spectrum into distinct wavelength ranges (UVC 280-315 nm, UVB 315-380 nm, UVA1 380-450 nm, and visible light 450-780 nm), allowing separate evaluation of sunscreen protection in each domain. This segmentation enables comprehensive testing of protection efficacy across all relevant spectral regions while maintaining structured, manageable test protocols.
2Reliability
If broad spectrum sunscreen is used, then protection against short wavelength UVA is improved, but protection against long wavelength UVA1 and visible light remains minimal
Solution Approach 1:
The patent employs parameter changes by measuring sunscreen absorbance across multiple wavelength parameters (280-780 nm range) rather than a single parameter. By calculating critical wavelengths at different spectral boundaries (315 nm, 380 nm, 450 nm, 780 nm) and evaluating area under the curve for each segment, the method adapts to evaluate diverse sunscreen formulations with varying spectral profiles, including those designed for UVA1 and visible light protection.
3Productivity
If critical wavelength method is used for evaluation, then testing efficiency is maintained, but assessment of long wavelength UVA1 and visible light protection is inadequate
Solution Approach 1:
The patent creates a universal testing framework that performs multiple functions: it calculates critical wavelengths at four different spectral boundaries (315 nm, 380 nm, 450 nm, 780 nm), evaluates area under the curve for each wavelength segment, and assesses both UV and visible light protection simultaneously. This multi-functional approach maintains testing efficiency while comprehensively evaluating protection across the entire 280-780 nm spectrum.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach effectively induces biologic effects such as changes in pigmentation and erythema, highlighting the need for protection in the VL and UVA1 domains, and providing a method for testing the efficacy of photoprotective substances against these forms of radiation.
Implementation Method 1
at least one customized filter for receiving the light beam and emitting a VL+UVA1 spectral output having a wavelength range of 370-700 nm
Data Source
AI summary
A system and method for testing an effect of light exposure on a skin sample include a solar simulator arranged to administer a combination of visible light (VL) and long wavelength ultraviolet radiation (UVA1) to the skin sample. The solar simulator includes a lamp for generating a light beam and at least one customized filter for receiving the light beam and emitting a VL+UVA1 spectral output having a wavelength range of 370-700 nm for irradiating the skin sample.


